Thomas W Grunt

Affiliations

Signaling Networks Program, Division of Oncology, Department of Medicine I, Comprehensive Cancer Center & Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.

Publications (9)

Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.

The Journal of experimental medicine

Avec: Qinglei Gao , Zongyuan Yang , Sen Xu , Xiaoting Li , Xin Yang , Ping Jin , Yi Liu , Xiaoshui Zhou , Taoran Zhang , Cheng Gong , Xiao Wei , Dan Liu , Chaoyang Sun , Gang Chen , Junbo Hu , Li Meng , Jianfeng Zhou , Kenjiro Sawada , Robert Fruscio , Thomas W Grunt , Jörg Wischhusen , Víctor Manuel Vargas-Hernández , Bhavana Pothuri , Robert L Coleman

A critical appraisal of the relative contribution of tissue architecture, genetics, epigenetics and cell metabolism to carcinogenesis.

Progress in biophysics and molecular biology

Avec: Thomas W Grunt , Gerwin Heller

Cancer - A devastating disease, but also an eye-opener and window into the deep mysteries of life and its origins.

Progress in biophysics and molecular biology

Avec: Thomas W Grunt , Peter Valent

Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.

International journal of oncology

Avec: Thomas W Grunt , Renate Wagner , Alexander Ries , Anna S Berghoff , Matthias Preusser , Michael Grusch , Peter Valent

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer.

Scientific reports

Avec: Thomas W Grunt , Astrid Slany , Mariya Semkova , Ramón Colomer , María Luz López-Rodríguez , Michael Wuczkowski , Renate Wagner , Christopher Gerner , Gerald Stübiger

The Pharmacological or Genetic Blockade of Endogenous

Frontiers in oncology

Avec: Thomas W Grunt , Lisa Lemberger , Ramón Colomer , María Luz López Rodríguez , Renate Wagner

Today's cancer research and treatment - highly sophisticated and molecularly targeted, yet firmly bolstered in the classical theories.

Journal of applied biomedicine

Avec: Thomas W Grunt

Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancer.

American journal of cancer research

Avec: Karin Bauer , Anna S Berghoff , Matthias Preusser , Gerwin Heller , Christoph C Zielinski , Peter Valent , Thomas W Grunt

Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer.

Cancers

Avec: Lisa Lemberger , Renate Wagner , Gerwin Heller , Dietmar Pils , Thomas W Grunt

Réseau de co-auteurs

Renate Wagner 4 collaborations

Gerwin Heller 3 collaborations

Peter Valent 3 collaborations

Anna S Berghoff 2 collaborations

Matthias Preusser 2 collaborations

Ramón Colomer 2 collaborations

Lisa Lemberger 2 collaborations

Qinglei Gao 1 collaboration

Zongyuan Yang 1 collaboration

Sen Xu 1 collaboration

Xiaoting Li 1 collaboration

Xin Yang 1 collaboration

Ping Jin 1 collaboration

Yi Liu 1 collaboration

Xiaoshui Zhou 1 collaboration

Taoran Zhang 1 collaboration

Cheng Gong 1 collaboration

Xiao Wei 1 collaboration

Dan Liu 1 collaboration

Chaoyang Sun 1 collaboration

Gang Chen 1 collaboration

Junbo Hu 1 collaboration

Li Meng 1 collaboration

Jianfeng Zhou 1 collaboration

Kenjiro Sawada 1 collaboration

Robert Fruscio 1 collaboration

Jörg Wischhusen 1 collaboration

Víctor Manuel Vargas-Hernández 1 collaboration

Bhavana Pothuri 1 collaboration

Robert L Coleman 1 collaboration

Alexander Ries 1 collaboration

Michael Grusch 1 collaboration

Astrid Slany 1 collaboration

Mariya Semkova 1 collaboration

María Luz López-Rodríguez 1 collaboration

Michael Wuczkowski 1 collaboration

Christopher Gerner 1 collaboration

Gerald Stübiger 1 collaboration

María Luz López Rodríguez 1 collaboration

Karin Bauer 1 collaboration

Christoph C Zielinski 1 collaboration

Dietmar Pils 1 collaboration